3.15
View the full transcript and gain access to JoVE Core videos
Q1: Why is the small intestine the primary site for drug absorption?
The small intestine, particularly the duodenum, is the primary absorption site due to its large surface area created by folds, villi, and microvilli. These structures, combined with a rich capillary network, enable rapid drug movement along the concentration gradient. The duodenum also neutralizes stomach acid, creating an optimal environment for drug absorption.
Q2: How does gastric emptying affect drug absorption timing?
Gastric emptying transfers drugs from the stomach to the small intestine and is the rate-limiting step in absorption. High-fat meals and cold beverages delay gastric emptying, prolonging the time before drugs reach the small intestine. This delay extends overall drug absorption time, affecting when therapeutic levels are reached.
Q3: What role does intestinal peristalsis play in drug absorption?
Intestinal peristalsis mixes drugs with digestive fluids and promotes contact with intestinal mucosal cells, typically requiring 1-4 hours for optimal absorption depending on drug formulation. Rapid motility in diarrhea causes insufficient absorption, while extended intestinal transit times allow complete drug absorption and better therapeutic outcomes.
Q4: Why does the stomach have limited role in drug absorption?
The stomach's high acidity and low surface area restrict drug absorption for most medications. Although GI motility initially moves drugs into the stomach, these anatomical limitations mean minimal absorption occurs there. The small intestine's superior design makes it the preferred site for most drug absorption.
Q5: How do villi and microvilli enhance drug absorption in the small intestine?
Villi and microvilli create an extensive surface area for drug contact with intestinal mucosal cells. This intricate anatomy, combined with proximity to a dense capillary network, facilitates rapid drug movement across the intestinal barrier. The increased surface area significantly enhances absorption efficiency compared to the stomach.
Q6: What happens to drug absorption when intestinal transit time is altered?
Intestinal transit time directly impacts drug absorption completeness. Rapid motility, as in diarrhea, reduces contact time between drugs and mucosal cells, leading to inadequate absorption. Conversely, extended transit times allow drugs sufficient time for complete absorption across the intestinal barrier.
Q7: How does the concentration gradient support drug movement in the small intestine?
The rich capillary network in intestinal villi maintains a concentration gradient that drives rapid drug movement from the intestinal lumen into systemic circulation. This gradient ensures continuous drug absorption as long as drug concentration in the intestine exceeds that in the blood, facilitating efficient transfer.